Maud Lemoine
Overview
Explore the profile of Maud Lemoine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
2457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riches N, Henrion M, MacPherson P, Hahn C, Kachala R, Mitchell T, et al.
Lancet Glob Health
. 2025 Feb;
13(3):e447-e458.
PMID: 40021303
Background: More new infections with hepatitis B virus (HBV) occur annually in the WHO African region than in the rest of the world combined. We did a systematic review and...
2.
Wong G, Lemoine M
J Hepatol
. 2024 Dec;
PMID: 39647534
Progress towards global elimination of hepatitis B virus (HBV) has been slow and most countries are far from reaching the elimination targets set out by the World Health Organization (WHO)....
3.
Ceesay A, Drammeh S, Ndow G, Jallow A, Nyang H, Bittaye B, et al.
Microorganisms
. 2024 Nov;
12(11).
PMID: 39597662
The GeneXpert HBV Viral Load test is a simplified tool to scale up screening and HBV monitoring in resource-limited settings, where HBV is endemic and where molecular techniques to quantify...
4.
Ndow G, Shimakawa Y, Leith D, Bah S, Bangura R, Mahmoud I, et al.
Lancet Gastroenterol Hepatol
. 2024 Nov;
9(12):1133-1146.
PMID: 39521002
Background: Expanding antiviral therapy to people with chronic hepatitis B virus (HBV) infection who are ineligible to receive treatment under current international criteria has been increasingly debated. Evidence to support...
5.
Lau D, Jackson K, Picchio C, Kramvis A, Sonderup M, Lemoine M, et al.
Lancet Gastroenterol Hepatol
. 2024 Sep;
9(12):1073-1076.
PMID: 39305916
No abstract available.
6.
The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa - Authors' reply
Minier N, Johannessen A, Sombie R, Lemoine M, Shimakawa Y
Lancet Gastroenterol Hepatol
. 2024 Jun;
9(7):589-590.
PMID: 38870961
No abstract available.
7.
Spearman C, Andersson M, Bright B, Davwar P, Desalegn H, Guingane A, et al.
BMC Glob Public Health
. 2024 May;
1(1):24.
PMID: 38798823
There are 82 million people living with hepatitis B (PLWHB) in the World Health Organization Africa region, where it is the main cause of liver disease. Effective vaccines have been...
8.
Vo-Quang E, Lemoine M
J Viral Hepat
. 2024 May;
31 Suppl 2:4-12.
PMID: 38797984
Hepatitis B virus (HBV) infection is a major cause of premature death worldwide. In 2016, the World Health Organization (WHO) called for HBV elimination and set up very ambitious elimination...
9.
Luong Nguyen L, Lemoine M, Ndow G, Nayagam S, Shimakawa Y
Lancet Glob Health
. 2024 May;
12(6):e917.
PMID: 38762294
No abstract available.
10.
Lacombe K, Moh R, Chazallon C, Lemoine M, Sylla B, Fadiga F, et al.
Sci Rep
. 2024 May;
14(1):10244.
PMID: 38702350
Access to Hepatis C treatment in Sub-Saharan Africa is a clinical, public health and ethical concern. The multi-country open-label trial TAC ANRS 12311 allowed assessing the feasibility, safety, efficacy of...